Principal Financial Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,117
Closed -$14K 2390
2020
Q1
$14K Buy
16,117
+528
+3% +$754 ﹤0.01% 2190
2019
Q4
$26K Sell
15,589
-6,928
-31% -$10.4K ﹤0.01% 2221
2019
Q3
$25K Buy
22,517
+5,996
+36% +$6.93K ﹤0.01% 2236
2019
Q2
$20K Buy
16,521
+4,474
+37% +$5.7K ﹤0.01% 2224
2019
Q1
$17K Sell
12,047
-539
-4% -$799 ﹤0.01% 2201
2018
Q4
$15K Sell
12,586
-7,266
-37% -$10.8K ﹤0.01% 2237
2018
Q3
$27K Buy
19,852
+7,411
+60% +$11.7K ﹤0.01% 2283
2018
Q2
$28K Buy
12,441
+1,665
+15% +$3.22K ﹤0.01% 2266
2018
Q1
$16K Sell
10,776
-7,044
-40% -$8.25K ﹤0.01% 2200
2017
Q4
$14K Buy
17,820
+5,549
+45% +$4.96K ﹤0.01% 2238
2017
Q3
$14K Sell
12,271
-646
-5% -$814 ﹤0.01% 2202
2017
Q2
$22K Buy
12,917
+1,482
+13% +$3.15K ﹤0.01% 2254
2017
Q1
$30K Buy
+11,435
New +$41.1K ﹤0.01% 2193
2016
Q3
Sell
-14,024
Closed -$25K 2203
2016
Q2
$25K Buy
+14,024
New +$28.6K ﹤0.01% 2156

Other funds holding GEN

Principal Financial Group's GEN Position: Q2 2020 in Review

Principal Financial Group sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 16,117 shares — an estimated $14K sold.

Principal Financial Group first reported a position in GEN in Q2 2016 and held it in 14 quarters. The position peaked at $30K in Q1 2017. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

  • Principal Financial Group reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
  • Principal Financial Group sold 16,117 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $14K.
  • Principal Financial Group first reported a position in Genesis Healthcare, Inc. in Q2 2016 and held it in 14 quarters.
  • Principal Financial Group's Genesis Healthcare, Inc. position peaked at $30K in Q1 2017.
  • 58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Principal Financial Group's 13F filing for Q2 2020, filed 5 Aug 2020.